NBIX
Neurocrine Biosciences Inc
Price:  
129.11 
USD
Volume:  
387,387.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

NBIX EV/EBITDA

-29.6%
Upside

As of 2025-07-06, the EV/EBITDA ratio of Neurocrine Biosciences Inc (NBIX) is 23.58. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. NBIX's latest enterprise value is 12,583.92 mil USD. NBIX's TTM EBITDA according to its financial statements is 533.60 mil USD. Dividing these 2 quantities gives us the above NBIX EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 13.1x - 16.2x 14.6x
Forward P/E multiples 13.5x - 15.3x 14.8x
Fair Price 72.59 - 104.46 90.86
Upside -43.8% - -19.1% -29.6%
129.11 USD
Stock Price
90.86 USD
Fair Price

NBIX EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-07-03 23.58
2025-07-02 23.64
2025-07-01 23.38
2025-06-30 22.95
2025-06-27 22.90
2025-06-26 23.14
2025-06-25 23.34
2025-06-24 23.41
2025-06-23 22.97
2025-06-20 23.11
2025-06-18 23.25
2025-06-17 22.80
2025-06-16 22.82
2025-06-13 22.71
2025-06-12 22.82
2025-06-11 22.67
2025-06-10 22.78
2025-06-09 22.96
2025-06-06 22.89
2025-06-05 22.75
2025-06-04 22.73
2025-06-03 22.82
2025-06-02 22.74
2025-05-30 22.45
2025-05-29 22.57
2025-05-28 22.46
2025-05-27 22.38
2025-05-23 21.93
2025-05-22 21.73
2025-05-21 22.00
2025-05-20 22.44
2025-05-19 22.42
2025-05-16 22.08
2025-05-15 21.94
2025-05-14 21.67
2025-05-13 21.31
2025-05-12 21.97
2025-05-09 21.10
2025-05-08 21.43
2025-05-07 22.19
2025-05-06 21.69
2025-05-05 19.99
2025-05-02 19.98
2025-05-01 19.41
2025-04-30 19.61
2025-04-29 19.53
2025-04-28 19.38
2025-04-25 19.43
2025-04-24 19.25
2025-04-23 18.78